Daily BriefsECM

Daily Brief ECM: Zeekr IPO Early Look – Possibly US$0 to US$7bn Revenue in Under Three Years and more

In today’s briefing:

  • Zeekr IPO Early Look – Possibly US$0 to US$7bn Revenue in Under Three Years
  • Honasa Consumer Pre-IPO – The Negatives – Ad Spending Keeping Profits Low
  • Fangzhou Pre-IPO – The Positives – Regulatory Changes and COVID Spurred Growth
  • Fiserv Inc.: Major Drivers
  • Amkor Technology Inc.: Expansion of European Supply Chain & Other Drivers
  • CVS Health Corporation: Acquisitions Of Oak Street Health & Signify Health
  • ZoomInfo Technologies Inc.: Major Drivers

Zeekr IPO Early Look – Possibly US$0 to US$7bn Revenue in Under Three Years

By Sumeet Singh

  • Zeekr, a premium EV brand by Geely, aims to raise around US$1bn (estimated) in its US listing in 1H2023. GS, BofA and MS are said to be running the deal.
  • Zeekr was formed in Mar 2021 as a JV between Geely and its founder. Its first model was launched in Apr 21 with deliveries starting in Oct 21.
  • In this note, we take an early look at the IPO based on publicly avaiable information.

Honasa Consumer Pre-IPO – The Negatives – Ad Spending Keeping Profits Low

By Sumeet Singh

  • Honasa Consumer (HC) is looking to raise about US$350m in its upcoming India IPO.
  • HC’s product portfolio includes products in the baby care, face care, body care, hair care, color cosmetics and fragrances segments.
  • In this note, we will talk about the not-so-positive aspects of the deal.

Fangzhou Pre-IPO – The Positives – Regulatory Changes and COVID Spurred Growth

By Clarence Chu

  • Fangzhou Group (FANGZHOU HK) is looking to raise about US$300m in its upcoming Hong Kong IPO.
  • Fangzhou (FZ) is an online chronic disease management (CDM) service provider in China.
  • In this note, we will talk about the positive aspects of the deal.

Fiserv Inc.: Major Drivers

By Baptista Research

  • Fiserv had a decent 2022 and managed to surpass the revenue expectations of Wall Street in its last result.
  • The company’s better-than-expected growth against the challenging backdrop was a result of growth in organic revenue, improvement in operating margin, and adjusted earnings per share.
  • Fiserv also advanced its core banking cloud roadmap for its new and existing clients with the acquisition and integration of Finxact.

Amkor Technology Inc.: Expansion of European Supply Chain & Other Drivers

By Baptista Research

  • Amkor produced a mixed set of results for the fourth-quarter with revenues of $1.9 billion that were above analyst expectations.
  • Demand for premium-tier smartphones was stronger than anticipated, while the automotive and industrial markets outperformed other markets where demand was weaker.
  • The demand for innovative packaging and infotainment systems helped the company was strong in the automotive and industrial sectors.

CVS Health Corporation: Acquisitions Of Oak Street Health & Signify Health

By Baptista Research

  • CVS Health has been on an acquisition spree lately and has been in the news for the acquisitions of Oak Street Health and Signify Health.
  • The company delivered strong financial results that exceeded the revenue expectations as well as earnings expectations of Wall Street with high single-digit top-line growth.
  • CVS recently announced that it has entered into one definitive agreement to acquire the outstanding shares of Oak Street Health.

ZoomInfo Technologies Inc.: Major Drivers

By Baptista Research

  • Even in the face of a challenging economic environment, Zoominfo Technologies delivered an all-around beat with strong revenue growth in the last quarter.
  • Structurally, Zoominfo is a profitable company committed to driving top-line growth while efficiently growing free cash flow and expanding profitability.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars